Details for New Drug Application (NDA): 084931
✉ Email this page to a colleague
NDA 084931 describes METHAMPHETAMINE HYDROCHLORIDE, which is a drug marketed by Able, Dr Reddys Labs Sa, Hikma, Rexar, and Teva, and is included in five NDAs. It is available from two suppliers. Additional details are available on the METHAMPHETAMINE HYDROCHLORIDE profile page.
The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
The generic ingredient in METHAMPHETAMINE HYDROCHLORIDE is methamphetamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the methamphetamine hydrochloride profile page.
Summary for 084931
| Tradename: | METHAMPHETAMINE HYDROCHLORIDE |
| Applicant: | Rexar |
| Ingredient: | methamphetamine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 084931
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 5MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Profile for product number 002
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | TABLET;ORAL | Strength | 10MG | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
